Must we reconsider the regulation of medicinal cannabis?
Text by Aleksi Hupli, Ph.D. candidate, University of Tampere Finland Full plant cannabis medication is a difficult fit in the Big Pharma model due to its complex chemical content. So the question is, which one needs to change; the system of regulating medical products or the way we the think of cannabis as medicine? As […]
